← Leaderboards
Eric Eichenwald
Children'S Hospital Boston
$300,487
Attributed
$300,487
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $23.6K · FY2005–11$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$300,487 · 9
By mechanism
M01$300,487 · 9
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Stella Kourembanas$24,289,131
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHuman DataInfantSafetySourceGrantFundingResourcesUnited States National Institutes Of HealthDoseClinical TrialsAge DifferenceEscherichia ColiComputer Retrieval Of Information On Scientific Projects DatabaseDisease /Disorder Proneness /RiskHeart RateBrain CirculationBactericidal ImmunityBaroreflexBacteria Infection MechanismBrain InjuryBlood PressureAdult Human (21+)
Grant awards (16)
TRIAL OF LATE SURFACTANT TO PREVENT BRONCHOPULMONARY$4,155
M01 · FY2011 · RR · contact PI
TRIAL OF LATE SURFACTANT TO PREVENT BRONCHOPULMONARY$21,116
M01 · FY2010 · RR · contact PI
FLUCONAZOLE PROPHYLAXIS FOR THE PREVENTION OF CANDIDIASIS IN INFANTS <750 GRAMS$2,060
M01 · FY2010 · RR · contact PI
MULTIPLE DOSE PHARMACOKINETIC STUDY OF MEROPENEM IN YOUNG INFANTS (<91 DAYS)$458
M01 · FY2010 · RR · contact PI
TRIAL OF LATE SURFACTANT TO PREVENT BRONCHOPULMONARY$9,643
M01 · FY2009 · RR · contact PI
LOW DOSE INHALED NITRIC OXIDE FOR TREATMENT AND PREVENTION$9,232
M01 · FY2006 · RR · contact PI
LOW DOSE INHALED NITRIC OXIDE FOR TREATMENT AND PREVENTION$23,042
M01 · FY2005 · RR
Low Dose Inhaled Nitric Oxide for Treatment and Prevention$657
M01 · FY2004 · RR
NEONATAL HOST DEFENSE: BACTERICIDAL &PERMEABILITY INCREASING PROTEIN$28,781
M01 · FY2002 · RR
VARIABILITY OF HEART RATE, BLOOD PRESSURE &CEREBRAL OXYGENATION: LBW NEONATES$28,750
M01 · FY2002 · RR
NEONATAL HOST DEFENSE: BACTERICIDAL &PERMEABILITY INCREASING PROTEIN$28,781
M01 · FY2001 · RR
NEONATAL HOST DEFENSE: BACTERICIDAL &PERMEABILITY INCREASING PROTEIN$28,781
M01 · FY2001 · RR
VARIABILITY OF HEART RATE, BLOOD PRESSURE &CEREBRAL OXYGENATION: LBW NEONATES$28,750
M01 · FY2001 · RR
VARIABILITY OF HEART RATE, BLOOD PRESSURE &CEREBRAL OXYGENATION: LBW NEONATES$28,750
M01 · FY2001 · RR
NEONATAL HOST DEFENSE: BACTERICIDAL &PERMEABILITY INCREASING PROTEIN$28,781
M01 · FY2000 · RR
VARIABILITY OF HEART RATE, BLOOD PRESSURE &CEREBRAL OXYGENATION: LBW NEONATES$28,750
M01 · FY2000 · RR